0000950123-22-002445.txt : 20220214
0000950123-22-002445.hdr.sgml : 20220214
20220214081441
ACCESSION NUMBER: 0000950123-22-002445
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20211231
FILED AS OF DATE: 20220214
DATE AS OF CHANGE: 20220214
EFFECTIVENESS DATE: 20220214
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: TRV GP II, LLC
CENTRAL INDEX KEY: 0001614073
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-18419
FILM NUMBER: 22625468
BUSINESS ADDRESS:
STREET 1: THIRD ROCK VENTURES
STREET 2: 29 NEWBURY STREET, 3RD FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 617-585-2000
MAIL ADDRESS:
STREET 1: THIRD ROCK VENTURES
STREET 2: 29 NEWBURY STREET, 3RD FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
13F-HR
1
primary_doc.xml
13F-HR
LIVE
0001614073
XXXXXXXX
12-31-2021
12-31-2021
false
TRV GP II, LLC
Third Rock Ventures
29 Newbury Street, 3rd Floor
Boston
MA
02116
13F HOLDINGS REPORT
028-18419
N
Kevin Gillis
Chief Operating Officer
617-585-2000
/s/ Kevin Gillis
Boston
MA
02-14-2022
3
2
24181
false
1
028-18439
Mark Levin
2
028-18438
Kevin P. Starr
3
028-18419
Robert I. Tepper
INFORMATION TABLE
2
10266.xml
INFORMATION TABLE FOR FORM 13F
JOUNCE THERAPEUTICS, INC.
COM
481116101
22527
2697829
SH
DFND
1,2,3
2697829
0
0
ALLENA PHARMACEUTICALS, INC.
COM
018119107
1654
2790964
SH
DFND
1,2,3
2790964
0
0